Two Extended-Release Buprenorphine Doses Effective in High-Risk Opioid Use Disorder

By News Health
48 minutes Ago

(MedPage Today) — Two dose levels of maintenance treatment with extended-release buprenorphine (Sublocade) improved opioid abstinence in patients with high-risk opioid use disorder (OUD), a randomized trial showed.
After two buprenorphine injections…

Source link : https://www.medpagetoday.com/psychiatry/opioids/119069

Author :

Publish date : 2025-12-17 21:39:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Major Developments in Psoriatic Disease

ADHD App Cleared; Anti-Inflammatories for Depression; Charges Over Adderall Scripts

Big Bump in Concierge, Direct Primary Care in Recent Years

Undesired Weight Gain Common in HIV Patients on ART

Improving Oral Chemotherapy Adherence in Pediatric ALL

Can an AI-Based Tool Help Predict Cardiovascular Events?